{"id":"https://openalex.org/W1488318878","doi":null,"title":"Combination chemotherapy with a new anthracycline glycoside, aclacinomycin-A, and active drugs for malignant lymphomas in P388 mouse leukemia system.","display_name":"Combination chemotherapy with a new anthracycline glycoside, aclacinomycin-A, and active drugs for malignant lymphomas in P388 mouse leukemia system.","alternate_titles":[],"publication_year":1979,"publication_date":"1979-08-01","ids":{"openalex":"https://openalex.org/W1488318878","mag":"1488318878","pmid":"https://pubmed.ncbi.nlm.nih.gov/92432"},"language":"en","primary_location":{"id":"pmid:92432","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/92432","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gan","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W1488318878"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113943675","display_name":"Shuichi Fujimoto","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"S Fujimoto","raw_affiliation_strings":["Division of Clinical Chemotherapy, Cancer Chemotherapy Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Clinical Chemotherapy, Cancer Chemotherapy Center","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059362468","display_name":"Jiro Inagaki","orcid":"https://orcid.org/0000-0001-8012-0501","observed_orcids":["https://orcid.org/0000-0001-8012-0501"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J Inagaki","raw_affiliation_strings":["Division of Clinical Chemotherapy, Cancer Chemotherapy Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Clinical Chemotherapy, Cancer Chemotherapy Center","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017078434","display_name":"Noboru Horikoshi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"N Horikoshi","raw_affiliation_strings":["Division of Clinical Chemotherapy, Cancer Chemotherapy Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Clinical Chemotherapy, Cancer Chemotherapy Center","institution_ids":[]}]},{"author_position":"last","author":{"id":null,"display_name":"M Ogawa","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M Ogawa","raw_affiliation_strings":["Division of Clinical Chemotherapy, Cancer Chemotherapy Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Clinical Chemotherapy, Cancer Chemotherapy Center","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.3703,"has_fulltext":false,"cited_by_count":7,"citation_normalized_percentile":{"value":0.78039794,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":93},"biblio":{"volume":"70","issue":"4","first_page":"411","last_page":"420"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.7318999767303467,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.7318999767303467,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12356","display_name":"Bioactive Compounds and Antitumor Agents","score":0.08860000222921371,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.04190000146627426,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/aclacinomycin-a","display_name":"aclacinomycin A","score":0.9860000014305115},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.8999999761581421},{"id":"https://openalex.org/keywords/lymphoma","display_name":"lymphoma","score":0.8489999771118164},{"id":"https://openalex.org/keywords/p388-leukemia","display_name":"P388 leukemia","score":0.9020000100135803},{"id":"https://openalex.org/keywords/doxorubicin-resistance","display_name":"doxorubicin resistance","score":0.8899999856948853},{"id":"https://openalex.org/keywords/cardiotoxicity","display_name":"cardiotoxicity","score":0.8169999718666077},{"id":"https://openalex.org/keywords/cyclophosphamide","display_name":"cyclophosphamide","score":0.8980000019073486},{"id":"https://openalex.org/keywords/vincristine","display_name":"vincristine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/procarbazine","display_name":"procarbazine","score":0.984000027179718},{"id":"https://openalex.org/keywords/bleomycin","display_name":"bleomycin","score":1.0},{"id":"https://openalex.org/keywords/drug-synergy","display_name":"drug synergy","score":0.6840000152587891},{"id":"https://openalex.org/keywords/treatment-schedule","display_name":"treatment schedule","score":0.6259999871253967}],"concepts":[{"id":"https://openalex.org/C2779429289","wikidata":"https://www.wikidata.org/wiki/Q408977","display_name":"Vincristine","level":4,"score":0.799119234085083},{"id":"https://openalex.org/C2779112685","wikidata":"https://www.wikidata.org/wiki/Q418656","display_name":"Procarbazine","level":5,"score":0.7912241816520691},{"id":"https://openalex.org/C2776802502","wikidata":"https://www.wikidata.org/wiki/Q417589","display_name":"Anthracycline","level":4,"score":0.6833975911140442},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.6624400019645691},{"id":"https://openalex.org/C2780847677","wikidata":"https://www.wikidata.org/wiki/Q4674302","display_name":"Aclarubicin","level":4,"score":0.6293100118637085},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.5909177660942078},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.587142288684845},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5630612373352051},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4859119951725006},{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.4663006365299225},{"id":"https://openalex.org/C2778233292","wikidata":"https://www.wikidata.org/wiki/Q2118956","display_name":"Cardiotoxicity","level":3,"score":0.45198336243629456},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4283333420753479},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2454530894756317},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2352837324142456},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.14534348249435425},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.06047022342681885}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000903","descriptor_name":"Antibiotics, Antineoplastic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001761","descriptor_name":"Bleomycin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007941","descriptor_name":"Leukemia P388","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D007942","descriptor_name":"Leukemia, Experimental","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008223","descriptor_name":"Lymphoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009279","descriptor_name":"Naphthacenes","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011344","descriptor_name":"Procarbazine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014750","descriptor_name":"Vincristine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"pmid:92432","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/92432","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gan","raw_type":"Journal Article"},{"id":"pmh:oai:mouseion.jax.org:ssbb1979-1646","doi":null,"is_oa":false,"landing_page_url":"https://mouseion.jax.org/ssbb1979/647","pdf_url":null,"source":{"id":"https://openalex.org/S4377196421","display_name":"The Mouseion at the JAXlibrary (Jackson Laboratory)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210115256","host_organization_name":"Jackson Laboratory","host_organization_lineage":["https://openalex.org/I4210115256"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Subject Strain Bibliography 1979","raw_type":"text"},{"id":"mag:1488318878","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/92432","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null},{"id":"mag:1572316906","doi":null,"is_oa":false,"landing_page_url":"http://ci.nii.ac.jp/naid/40000529371","pdf_url":null,"source":{"id":"https://openalex.org/S4306555421","display_name":"\u764c","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"\u764c","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1977647320","https://openalex.org/W99886386","https://openalex.org/W203224894","https://openalex.org/W2439120652","https://openalex.org/W2400044807","https://openalex.org/W1981292619","https://openalex.org/W2885983999","https://openalex.org/W2415029639","https://openalex.org/W2419507504","https://openalex.org/W2325777487"],"abstract_inverted_index":{"Aclacinomycin-A":[0,54],"is":[1],"a":[2,21,49,148],"new":[3],"anthracycline":[4],"glycoside":[5],"and":[6,64,94],"has":[7],"less":[8],"cardiotoxicity":[9],"than":[10,74],"adriamycin.":[11],"In":[12],"an":[13,17,109,123],"attempt":[14],"to":[15,106],"provide":[16],"experimental":[18],"model":[19],"of":[20,25,31,37,39,68,76,111,126,131,141],"phase":[22],"III":[23],"study":[24],"aclacinomycin-A,":[26],"particularly":[27],"for":[28],"the":[29,65,139],"treatment":[30,57,80,84],"malignant":[32],"lymphomas,":[33],"various":[34],"therapeutic":[35,149],"designs":[36],"combinations":[38,130,140],"this":[40,61,69],"drug":[41,70],"with":[42,133,143],"other":[43,101],"conventional":[44],"agents":[45],"were":[46],"investigated":[47],"using":[48],"P388":[50,127,152],"mouse":[51],"leukemia":[52,153],"system.":[53,154],"showed":[55,147],"no":[56],"schedule":[58],"dependency":[59],"in":[60,151],"tumor":[62],"system":[63],"optimal":[66],"dosage":[67],"was":[71,120],"twice":[72],"higher":[73],"that":[75],"adriamycin":[77],"on":[78,85,90,99,115],"each":[79],"schedule;":[81],"i.e.,":[82],"single":[83],"day":[86,102,116],"1,":[87,92],"three":[88],"treatments":[89,98],"days":[91,104],"5,":[93],"9,":[95],"or":[96,137,145],"10":[97],"every":[100],"from":[103],"1":[105],"19":[107],"after":[108],"inoculation":[110],"10(6)":[112],"leukemic":[113],"cells":[114],"0.":[117],"This":[118],"antibiotic":[119],"ineffective":[121],"against":[122],"adriamycin-resistant":[124],"subline":[125],"leukemia.":[128],"Among":[129],"aclacinomycin-A":[132,142],"cyclophosphamide,":[134],"vincristine,":[135],"procarbazine,":[136],"bleomycin,":[138],"cyclophosphamide":[144],"vincristine":[146],"synergism":[150]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1488318878","counts_by_year":[{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
